A next-generation techbio company developing precision medicines for inflammatory and immune-mediated diseases
Graph Therapeutics has raised €4.4M across 1 funding round from 1 investor, most recently a round in Jun 2026. Based in Vienna, Austria; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-22 | Other | €4.4M |
| Daphni |
| View deal → |
